Mark C. Schneyer, EVP, Chief Financial Officer at ACADIA PHARMACEUTICALS INC (ACAD), sold 10,000 shares at $29.00 ($290K) on 2023-08-21, disclosed to the SEC on 2023-08-23.
Scheduled sale ($290k) by EVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ACAD | SELL | 2026-04-07 | $60K | — | Filing → |
| ACAD | SELL | 2026-03-26 | $160K | — | Filing → |
| ACAD | SELL | 2025-11-19 | $486K | — | Filing → |